Skip to main content
Our Blog · Field notes

Our Blog

Practical posts on CPOM, PC/MSO structure, marketing, credentialing, and payors — plus downloadable checklists and state-by-state tools.

Latest posts

Latest articles

33 posts
Enforcement
Privacy & WebPatient Advocacy

Five More States Join the FTC Lawsuit Against Hims & Hers: Why the State Layer Matters for Telehealth

Arizona, Florida, Nebraska, Ohio, and Wisconsin joined the FTC's case against Hims & Hers on November 10. Here is what changed, why the state layer matters, and what telehealth companies should take from it.

Read
Playbook
TelehealthDigital Health

10 Common Compliance Mistakes in Telemedicine and Digital Health

The ten compliance mistakes I see most often in telemedicine and digital health, from CPOM and job descriptions to tracking pixels, marketing, and branded vials, and what is in the news that shows why they matter now.

Read
Industry Move
Private PracticeMedicare & Medicaid

Duet's NP-Led ACO and the Rise of NPs and PAs as Practice Owners

Duet raised $15 million and plans to launch what it calls the first NP-led Medicare ACO in 2027. It is a clear sign that nurse practitioners and physician associates are moving from workforce to ownership and leadership.

Read
Rule Change
Medicare & MedicaidPatient Advocacy

Why CMS Delayed Enforcement of Medicaid Work Requirements Until July 2027

CMS is giving states until July 1, 2027 before they have to deny or disenroll anyone under the new Medicaid work requirements. Here is what changed, why delays like this happen, and what it means for providers.

Read
Playbook
Scope & TitlesMarketing

Calling Yourself "Dr." in a Clinical Setting: What State Law Says for NPs, PAs, and Chiropractors

Using "Dr." with patients when you are not an MD or DO can break state law. Here is what California, Georgia, Texas, Florida, Tennessee, and Indiana require, and how NPs, PAs, and chiropractors can use their doctorate safely.

Read
Rule Change
TelehealthDigital Health

Healthcare Changes Coming in 2027: What Telehealth Companies and Practices Should Know

Most of what was debated in 2026 takes effect in 2027: DEA telemedicine prescribing flexibilities end, California's healthcare AI laws start, Medicare adds telehealth modifiers, Maine requires transaction approval, FDA reviews more peptides, and CPOM pressure continues. Here is what is coming, in date order, and who each change affects.

Read
Enforcement
Peptides & GLP-1sScope & Titles

State Medical Boards Are Putting Peptide Prescribers on Notice: What South Carolina, Mississippi, and Alabama Said

What Alabama, Mississippi, and South Carolina board notices mean for peptide prescribers, consent forms, delegation, and pharmacy sourcing.

Read
Rule Change
AIDigital Health

California's New AI in Healthcare Laws: What AB 1979 and SB 503 Mean for Practices and Digital Health Companies

California’s AB 1979 and SB 503 set new rules for clinical AI, chatbot privacy, and bias documentation. What practices should review before January 2027.

Read
Rule Change
AIPatient Advocacy

Utah Approved AI to Write First-Time Prescriptions. Here Is Where We Stand.

Utah authorized Nolla Health's AI to issue first-time acne prescriptions — the first approval of its kind. Here is what the pilot allows, why the scaled-back physician oversight is the real concern, and what it means if you are building in healthcare.

Read
Investigation
MarketingPeptides & GLP-1s

Why LegitScript Is in the News for Not Overseeing Vendors Correctly

CBS News found sellers promoting retatrutide while displaying LegitScript certification. What it means for telehealth companies, ad platforms, payment processors, and your own vendor oversight.

Read
Rule Change
CPOM & MSOTelehealth

The Stop Corporate Takeovers of Physicians Act: What It Would Mean for Digital Health and Telemedicine

The proposed federal CPOM bill reaches well beyond private equity. Here is what it would change for PC/MSO structures, physician owners, stock transfer agreements, and telehealth branding.

Read
Rule Change
Peptides & GLP-1sTelehealth

White House Plans Temporary Access to Six Peptides: What It Means for Providers and Telehealth

Reported temporary peptide access is not FDA approval. What providers should know about compounding, prescribing, marketing, and state-law guardrails.

Read
Playbook
Digital HealthTelehealth

What a Corrective Action Plan Is—and Why Your Company Needs a Process for It

A corrective action plan is not punishment. It is a documented process for finding compliance gaps, fixing them, proving the fix, and preventing the same issue from returning.

Read
Rule Change
CPOM & MSOTelehealth

Telemedicine Startups: California Just Made Your Next Deal and Your MSO Structure a Legal Liability

California's OHCA transaction notice rules, SB 351, and AB 1415 now put PE- and VC-backed telemedicine platforms and their MSO structures under direct state scrutiny — plus what Oregon, Washington, and the DEA are doing next.

Read
Enforcement
Peptides & GLP-1sMarketing

Eli Lilly Sues Six Retatrutide Sellers: What the Filings Mean for Med Spas, Compounders, and Telehealth

Eli Lilly filed six lawsuits over black-market retatrutide and referred 200+ individuals and entities to regulators and licensing boards. Here is what is actually in the filings, why the manufacturer was always the more likely plaintiff, and the sourcing, marketing, and structure review med spas, compounding pharmacies, and telehealth operators should run now.

Read
Playbook
Privacy & WebPatient Advocacy

Website Accessibility for Healthcare Practices: Serial Lawsuits vs. What the Government Actually Requires

ADA website lawsuits and the HHS Section 504 web rule are two different problems. What healthcare practices owe, the 2027 and 2028 deadlines, and what to do.

Read
Playbook
Billing & CoverageTelehealth

Claims-Made vs. Occurrence Malpractice Coverage for Telemedicine Clinicians

A plain-language explainer on claims-made vs. occurrence malpractice coverage, tail endorsements, retroactive dates, and what changes in telemedicine.

Read
Enforcement
TelehealthPrivacy & Web

What the FTC Lawsuit Against Hims & Hers Means for Telehealth Companies

The FTC sued Hims & Hers under Section 5 and ROSCA, not telehealth law. What it signals about tracking pixels, intake-to-charge billing, and MSO/PC exposure.

Read
Playbook
MarketingDigital Health

What LegitScript Certification Actually Is, When You Need It, and How to Get Through It

LegitScript certification, explained plainly: what it is, why Stripe and Meta require it, who actually needs it, and how to prepare so the audit does not derail you.

Read
Enforcement
Privacy & WebPrivate Practice

ADA Website Accessibility Lawsuits Are Rising. What Private Practice Clinicians Need to Know.

ADA website accessibility lawsuits rose 27% in 2025. Here's what private practice clinicians need to know about WCAG, demand letters, and real risk reduction.

Read
Playbook
CPOM & MSOScope & Titles

Beyond CPOM and Supervision: Why Specialty and Scope of Practice Decide Whether a Practice Holds Up

A clean CPOM and supervision setup can still fail. Specialty, scope of practice, and facility rules decide whether your clinical model actually holds up.

Read
Playbook
Billing & CoveragePrivate Practice

What Is a Superbill? Why Cash-Pay Practices Still Need One

A superbill is an itemized patient receipt that unlocks HSA, FSA, and out-of-network reimbursement. Here's what cash-pay practices must include.

Read
Rule Change
TelehealthScope & Titles

DEA Registration for Telehealth Prescribers: What Digital Health Companies Should Fix Before 2027

The COVID-era DEA telemedicine flexibilities expire December 31, 2026. Here is what digital health platforms should audit now — registration geography, home addresses, state CSRs, and PDMP workflow — before the rule tightens.

Read
Enforcement
CPOM & MSOTelehealth

The Carbon Health CPOM Settlement: What It Means for Telemedicine and Digital Health using friendly PC/MSO model

California's $4.5 million settlement with Carbon Health is the first time the Attorney General has forced a company to tear down and rebuild a friendly-PC structure. Here's what telemedicine founders need to know.

Read
Enforcement
Peptides & GLP-1sMarketing

Retatrutide and Compounding: What the Regulations Say and the Enforcement Records are Showing

An educational overview of the regulatory and enforcement landscape around retatrutide — what the FDA warning letters, state pharmacy records, and testing data actually show.

Read
Enforcement
CPOM & MSOPrivate Practice

Restricted Transfer Agreements in MSO/PC Structures: What They Do, Why California Is Different, and Why the AG Just Sent a Warning Shot

If you operate a friendly PC structure, there is a document in your stack that almost nobody outside the deal team ever reads. It goes by several names: restricted transfer agreement, stock transfer restriction agreement, succession…

Read
Rule Change
Medicare & MedicaidPeptides & GLP-1s

How to Get GLP-1 Coverage on Medicare in 2026: A Provider's Guide to the New Bridge Program

For as long as GLP-1 medications have existed, the answer to "does Medicare cover this for weight loss" has been no. Not because of a coverage policy anyone could appeal, but because federal law excludes drugs used for weight loss from…

Read
Enforcement
TelehealthScope & Titles

Telehealth Provider Misclassification: What the Cioppettini v. Mochi Medical Lawsuit Means for 1099 Clinician Contracts

Almost every telehealth company I work with pays at least some of its clinicians on a 1099. Usually the reasoning is the same. The clinicians set their own hours, they work for other companies too, they are licensed professionals…

Read
Investigation
TelehealthPatient Advocacy

Medvi and Zealthy: What Every Telehealth Founder Needs to Learn From Compliance Investigations in 2026

Two telehealth companies were in the news this spring for very different reasons and at very different stages of trouble. One received an FDA warning letter as part of a broad enforcement sweep and has faced press scrutiny over its…

Read
Playbook
Private PracticeCPOM & MSO

How to Start a Medical Practice in 2026: A Complete Guide

The full sequence for launching a practice in 2026 — model, entity structure and CPOM, licensure and DEA, contracts, insurance, banking, technology, credentialing, telehealth, and growth — with a realistic timeline and the mistakes we see most.

Read
Playbook
Private PracticeDigital Health

Building a Team for a Start-Up: Healthcare Edition

Every healthcare company runs on the same seven departments. A full unit-by-unit breakdown of product, technology, operations, marketing, sales, support, and finance for private practices and digital health start-ups.

Read
Playbook
Scope & TitlesPrivate Practice

The Final Step Most Miss: Mandatory Board Submissions for NP and PA Collaborative Agreements

A signed collaborative or supervision agreement is not always the last step. Many states require notification, registration, or board approval before an NP or PA sees patients — here is how to check, who files, and what triggers a new submission.

Read
Investigation
Medicare & MedicaidPrivate Practice

What Is a UPIC Audit? Everything Private Practice Owners Should Know

Most billing reviews are a nuisance. A UPIC audit is a different category of event, and the difference is worth understanding before one arrives rather than…

Read